AI Summary
✦ ClarthaLinde India is an industrial and medical gases manufacturer and supplier. Gases, Related Products and Services drive revenue through oxygen, nitrogen, and argon, supplied onsite, in bulk, and packaged. Project Engineering builds cryogenic and non-cryogenic air-separation plants, supporting industrial demand. Investors await Q1 results, which could clarify whether 1.8% revenue growth is improving. Profit growth of 20.7% outpaced revenue, while stable margins indicate earnings gains without operating deterioration. ROE is 13.6%, reflecting moderate returns rather than exceptional capital efficiency. At 109.9 times earnings, the stock is richly valued and trades at a substantial premium to its low-single-digit growth. The valuation leaves limited room for weaker industrial demand or disappointing Q1 execution.
Price Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 2 analysts
Fundamentals
Fundamentals institutional score is 46 using EVA spread proxy 1.6%; growth durability 24.0.
Valuation
Valuation institutional score is 58 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 19 using mean target upside -15.0%; dispersion penalty 1.6; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 65 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 4 recent ticker-linked news items.
Signal Summary
Market intelligence remains Mixed. technical structure provide support, while fundamentals and analyst consensus remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 10.4% above historical median. Valuation is rising — currently in the fair zone (z-score: +0.48). Confidence: 87%.
Live forward EPS implies next-12-month EPS of ₹86.85. Applying the stock's normalized valuation corridor produces a fair range of ₹7,992.81 to ₹9,651.64, with base value near ₹8,643.31 (+22.6% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹86.85
Forward P/E
81.2x
Base Fair Value
₹8,643.31
Fair Range
₹7,992.81 - ₹9,651.64
Upside To Base
+22.6%
Estimate Source
Live forward EPS
Growth Estimate
+676.4%
5Y Average
83.35
Current
109.90
Overvalued
111.13
Undervalued
92.03
5Y Average
14.30
Current
14.09
Overvalued
16.45
Undervalued
12.16
5Y Average
18.18
Current
23.75
Overvalued
22.65
Undervalued
12.11
Peers & Comparison
Sector: Materials · Theme: Commodity Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
HIMADRI SPECIALITY CHEM L HSCLCommodity Chemicals | +28.0% | 16.1% | 48.4x Undervalued | -27% vs avg | +68.6% |
SOLAR INDUSTRIES (I) LTD SOLARINDSCommodity Chemicals | +40.9% | 17.1% | 101.9x Premium | +54% vs avg | +25.2% |
GARWARE HI-TECH FILMS LTD GRWRHITECHCommodity Chemicals | +31.9% | 17.1% | 48.0x Undervalued | -27% vs avg | +145.3% |
LINDE INDIA LIMITED trades at a premium (108.9x vs peer avg 66.1x), implying higher growth or quality expectations from the Commodity Chemicals cohort. Peers include HIMADRI SPECIALITY CHEM L, SOLAR INDUSTRIES (I) LTD, GARWARE HI-TECH FILMS LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹614 CrMar 2026Latest net profit
₹85 CrMar 2026Latest EPS
₹9.99Mar 2026Net margin
28.0%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 630 | 721 | 711 | 706 | 630 | 653 | 634 | 606 | 592 | 571 | 644 | 701 | 614 |
| Expenses + | 444 | 557 | 538 | 520 | 452 | 469 | 456 | 414 | 382 | 374 | 362 | 444 | 441 |
| Operating Profit | 186 | 164 | 174 | 186 | 179 | 184 | 179 | 192 | 210 | 197 | 282 | 257 | 173 |
| OPM % | 30% | 23% | 24% | 26% | 28% | 28% | 28% | 32% | 35% | 34% | 44% | 37% | 28% |
| Other Income + | 22 | 18 | 19 | 22 | 18 | 19 | 16 | 19 | 13 | 4 | 4 | 53 | 6 |
| Interest | 2 | 1 | 1 | 1 | 4 | 2 | 2 | 2 | 7 | 3 | 3 | 6 | 3 |
| Depreciation | 66 | 49 | 50 | 51 | 52 | 51 | 52 | 55 | 56 | 56 | 56 | 62 | 61 |
| Profit before tax | 140 | 132 | 141 | 156 | 141 | 150 | 141 | 155 | 161 | 142 | 226 | 243 | 115 |
| Tax % | 30% | 26% | 24% | 25% | 26% | 25% | 26% | 26% | 27% | 26% | 25% | 21% | 26% |
| Net Profit + | 99 | 98 | 107 | 117 | 104 | 112 | 104 | 114 | 118 | 105 | 169 | 192 | 85 |
| EPS in Rs | 11.58 | 11.51 | 12.51 | 13.74 | 12.23 | 13.08 | 12.24 | 13.37 | 13.82 | 12.32 | 19.82 | 22.46 | 9.99 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Board Meeting Intimation for Adjournment Of Board Meeting For Approval Of The Unaudited Financial Results For The Quarter Ended 30 June 2026
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026